Literature DB >> 16068182

Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man.

M Y Gordon, J W Singer.   

Abstract

THE properties of the fungus metabolite, cyclosporin A, have suggested its potential as a clinically valuable immunosup-pressive agent(1,2). Experiments in animals have demonstrated that its suppressive action against cell-mediated and humoral immunity is not accompanied by any appreciable myelotoxicity(3,4). In this respect, cyclosporin A contrasts with other immunosuppressants in current use, such as antilymphocyte globulin and azathioprine. There are, however, few data to substantiate a selective toxicity of cyclosporin A against human lymphocytes. Here, we have compared its effects against human lymphoid and myeloid cells, using colony formation by the different cell types as the end point. We found that the compound exhibited far greater toxicity towards a sub-population of T cells than towards either B lymphocytes or haematopoietic precursor cells.

Entities:  

Year:  1979        PMID: 16068182     DOI: 10.1038/279433a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

Review 1.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

2.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

3.  Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Authors:  Y Novik; L Oleksowicz; P H Wiernik
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

4.  Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.

Authors:  A W Thomson; D K Moon; D S Nelson
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

5.  Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations.

Authors:  T Paavonen; H Järveläinen; S Kontiainen; P Häyry
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

6.  Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation.

Authors:  R Foa; D Catovsky
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

Review 7.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

8.  Fatty acid metabolism and cell proliferation: IV. Effect of prostanoid biosynthesis from endogenous fatty acid release with cyclosporin-A.

Authors:  J A Lindsey; N Morisaki; J M Stitts; R A Zager; D G Cornwell
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

9.  Cyclosporin A: a new advance in transplantation.

Authors:  B D Kahan
Journal:  Tex Heart Inst J       Date:  1982-09

10.  T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors.

Authors:  B Fleming; G A Rook
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.